In-depth coverage of the latest IP & Copyright developments, trends, and analysis — curated daily.
A single missing inventor can now doom a patent forever. The Federal Circuit just proved it, striking down two patents in a ruling that exposes cracks in post-AIA law.
Picture Matthew McConaughey's drawl deciding your patent's fate: 'Alright, alright, alright.' USPTO just emailed that as an official April Fool's gag — and it's genius.
In a blow to patent holders, the Federal Circuit just ruled that 'allowing' a data packet counts as a patent claim's key 'action.' Centripetal's network security dreams? Dead on arrival.
Startups pouring cash into patents just got a rude wake-up. A single argument you make — and lose — during examination can torpedo your infringement suits years later.
Imagine your billion-dollar patent evaporating because one inventor ghosts you. That's Fortress Iron v. Digger Specialties, where the Federal Circuit just enforced a brutal post-AIA rule.
Two UC law profs just gutted the latest Patent Eligibility Reform Act. Their tweaks? Sharp. But will Congress listen, or keep chasing Alice ghosts?
Imagine squeezing a new air conditioner into your boat's cramped engine room—now, without a Federal Circuit patent smackdown, you won't pay extra for Chinese imports. But this ruling? It just rewired how hardware patents must spell out modularity.
Western Digital's last-second reexam filing smells like desperation—or genius gaming. USPTO's trying, but patent killers keep finding holes.
A Beverly Hills urologist's penile implant empire hangs by a thread in Federal Circuit arguments. Patents might just eviscerate his trade secret claims — bad news for anyone playing both IP sides.
A single Federal Circuit ruling just made life hell for owners of subcomponent patents. MRI's 'constricted convection' tech had killer evidence—yet it wasn't enough.
Patent challengers thought their original standing declaration would cover amended claims. Wrong. The Federal Circuit just said no, forcing fresh proof—and that's a game-changer for AI patent battles.
Think Big Pharma's patent tricks keep generics off shelves forever? Wrong. Data proves otherwise, yet Washington bites the myth anyway. Who's really cashing in?